首页|期刊导航|中国医学工程|外周血IL-6联合CD4+T淋巴细胞计数、CD8+PD-1+T细胞比例对肺炎患者疾病转归的预测价值

外周血IL-6联合CD4+T淋巴细胞计数、CD8+PD-1+T细胞比例对肺炎患者疾病转归的预测价值OA

Predictive value of peripheral blood IL-6 combined with CD4+T lymphocyte count and CD8+PD-1+T cell ratio for disease outcome in pneumonia patients

中文摘要英文摘要

目的 探讨外周血白细胞介素(IL-6)联合CD4+T淋巴细胞计数、CD8+PD-1+T细胞比例对肺炎患者疾病转归的预测价值.方法 回顾性分析2022年2月至2024年2月南阳市第一人民医院收治的肺炎患者106例临床资料,根据患者治疗7 d后的临床转归情况分为转归良好组(73例)和转归不良组(33例).检测并比较两组患者治疗前、治疗3 d后、治疗7 d后外周血IL-6水平、CD4+T淋巴细胞计数及CD8+PD-1+T细胞比例,采用Pearson相关性分析各指标间的相关性,通过受试者工作特征(ROC)曲线分析各指标单一及联合检测对肺炎患者疾病转归的预测价值.结果 组内比较显示,两组患者外周血IL-6水平、CD8+PD-1+T细胞比例均随治疗时间延长呈逐渐降低趋势,CD4+T淋巴细胞计数呈逐渐升高趋势(均P<0.05).组间比较显示,转归良好组各时间点外周血IL-6水平、CD8+PD-1+T细胞比例均低于转归不良组,CD4+T淋巴细胞计数均高于转归不良组(均P<0.05);Pearson相关性分析显示,肺炎患者治疗3 d、7 d后外周血IL-6水平与CD8+PD-1+T细胞比例呈正相关(r>0,P<0.05),与CD4+T淋巴细胞计数呈负相关(r<0,P<0.05);ROC曲线分析显示,外周血IL-6、CD4+T淋巴细胞计数、CD8+PD-1+T细胞比例联合检测对肺炎患者疾病转归的预测价值随治疗进程动态提升,其中治疗7 d后的联合检测预测效能最优.结论 肺炎患者外周血IL-6水平、CD4+T淋巴细胞计数、CD8+PD-1+T细胞比例与疾病转归密切相关,三者联合检测可作为肺炎患者疾病转归的有效预测指标.

[Objective]To explore the predictive value of peripheral blood interleukin-6(IL-6)combined with CD4+T lymphocyte count and CD8+programmed cell death protein 1-positive(PD-1+)T cell ratio for the disease outcome of pneumonia patients.[Methods]A retrospective collection of clinical data was conducted on 106 pneumonia patients admitted to Nanyang First People's Hospital from February 2022 to February 2024.Based on the patients'7-day outcomes(clinical efficacy),they were divided into a good outcome group(73 cases)and a poor outcome group(33 cases).The peripheral blood IL-6 combined with CD4+T lymphocyte count and PD-1+T cell ratio between two groups before treatment,3 days after treatment,and 7 days after treatment were compared.The predictive value of single and combined detection of the above indicators for the disease outcome of pneumonia patients was further analyzed.[Results]Intragroup comparison showed that in both groups,the peripheral blood IL-6 levels and the proportion of CD8⁺PD-1⁺ T cells gradually decreased over the treatment period,while the CD4⁺ T lymphocyte count gradually increased(all P<0.05).Intergroup comparison showed that at all time points,the peripheral blood IL-6 levels and the proportion of CD8 ⁺ PD-1 ⁺ T cells in the good outcome group were lower than those in the poor outcome group,while the CD4 ⁺ T lymphocyte count was higher than that in the poor outcome group(all P<0.05).Pearson correlation analysis showed that after 3 and 7 days of treatment,the peripheral blood IL-6 level in pneumonia patients was positively correlated with the proportion of CD8⁺PD-1⁺ T cells(r>0,P<0.05),and negatively correlated with the CD4⁺ T lymphocyte count(r<0,P<0.05).Receiver operating characteristic(ROC)curve analysis showed that the predictive value of combined detection of peripheral blood IL-6,CD4⁺ T lymphocyte count,and CD8⁺PD-1⁺ T cell proportion for disease outcome in pneumonia patients dynamically increased over the course of treatment,with the combined detection at 7 days after treatment having the optimal predictive performance.[Conclusion]The peripheral blood IL-6,CD4+T lymphocyte count,and CD8+PD-1+T cell ratio expression of pneumonia patients are closely related to disease progression,and combined detection has certain predictive value for patient disease progression.

史芳瑜;郝鹏飞;徐全晓;张丽柯

南阳市第一人民医院 河南省肿瘤分子生物学医学重点实验室,河南 南阳 473000南阳理工学院张仲景国医国药学院,河南 南阳 473004南阳市第一人民医院 河南省肿瘤分子生物学医学重点实验室,河南 南阳 473000南阳市第一人民医院 河南省肿瘤分子生物学医学重点实验室,河南 南阳 473000

医药卫生

肺炎白细胞介素-6CD4+T淋巴细胞计数CD8+PD-1+T细胞比例疾病转归

pneumoniainterleukin-6CD4+T lymphocyte countCD8+PD-1+T cell ratioprognosis

《中国医学工程》 2026 (3)

76-80,5

10.19338/j.issn.1672-2019.2026.03.013

评论